Last reviewed · How we verify
Cytomegaloviral retinitis
Approved treatments
- Cytovene · Roche Palo
GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication. - FOMIVIRSEN · Novartis
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Cytomegaloviral retinitis patent landscape — cliff calendar, originator estates, attackable patents
- Cytomegaloviral retinitis treatment landscape brief
- Cytomegaloviral retinitis treatment updates RSS
Frequently asked questions about Cytomegaloviral retinitis
What drugs treat Cytomegaloviral retinitis?
Tracked treatments include Cytovene, FOMIVIRSEN.
What is the treatment for Cytomegaloviral retinitis?
Standard treatment for Cytomegaloviral retinitis includes Cytovene, FOMIVIRSEN. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Cytomegaloviral retinitis patent cliff · Cytomegaloviral retinitis CI report
- Treatment: Cytovene · Roche Palo
- Treatment: FOMIVIRSEN · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing